- Home
- AUROW vs BBIO Comparison
AUROW vs BBIO Comparison
Compare AUROW & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUROW | BBIO |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.4B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AUROW | BBIO |
|---|---|---|
| Price | $0.32 | $74.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $75.75 |
| AVG Volume (30 Days) | 137.0K | ★ 2.0M |
| Earning Date | 04-30-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $353,780,000.00 |
| Revenue This Year | N/A | $128.44 |
| Revenue Next Year | N/A | $76.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 62.46 |
| 52 Week Low | $2.09 | $25.34 |
| 52 Week High | $3.00 | $75.10 |
Technical Indicators
Market Signals| Indicator | AUROW | BBIO |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 67.62 |
| Support Level | $0.30 | $70.35 |
| Resistance Level | $0.35 | $75.10 |
| Average True Range (ATR) | 0.04 | 2.32 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 40.13 | 96.45 |
Price Performance
Historical ComparisonAbout AUROW Aurora Innovation Inc. Warrant
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.